These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29162389)

  • 21. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.
    Rinaldi L; Nascimbeni F; Giordano M; Masetti C; Guerrera B; Amelia A; Fascione MC; Ballestri S; Romagnoli D; Zampino R; Nevola R; Baldelli E; Iuliano N; Rosato V; Lonardo A; Adinolfi LE
    World J Gastroenterol; 2017 Feb; 23(8):1458-1468. PubMed ID: 28293093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethnic differences in the prevalence of cryptogenic cirrhosis.
    Browning JD; Kumar KS; Saboorian MH; Thiele DL
    Am J Gastroenterol; 2004 Feb; 99(2):292-8. PubMed ID: 15046220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?
    Yopp AC; Choti MA
    Dig Dis; 2015 Sep; 33(5):642-7. PubMed ID: 26398208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
    Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
    Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
    Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
    BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study.
    Vaz J; Eriksson B; Strömberg U; Buchebner D; Midlöv P
    BMC Gastroenterol; 2020 Apr; 20(1):84. PubMed ID: 32245414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies.
    Nagai S; Collins K; Chau LC; Safwan M; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2759-2768.e5. PubMed ID: 31004758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver Transplant Outcomes in Young Adults with Cirrhosis Related to Nonalcoholic Fatty Liver Disease.
    Bezinover D; Alhkouri N; Schumann R; Geyer N; Chinchilli V; Stine JG
    Transplant Proc; 2023 Nov; 55(9):2134-2142. PubMed ID: 37752016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?
    Duclos-Vallée JC; Yilmaz F; Johanet C; Roque-Afonso AM; Gigou M; Trichet C; Féray C; Ballot E; Dussaix E; Castaing D; Bismuth H; Samuel D; Guettier C
    Clin Transplant; 2005 Oct; 19(5):591-9. PubMed ID: 16146549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis.
    Duseja A; Nanda M; Das A; Das R; Bhansali A; Chawla Y
    Trop Gastroenterol; 2004; 25(1):15-7. PubMed ID: 15303464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
    Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
    J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NASH and cryptogenic cirrhosis: a histological analysis.
    Caldwell SH; Lee VD; Kleiner DE; Al-Osaimi AM; Argo CK; Northup PG; Berg CL
    Ann Hepatol; 2009; 8(4):346-52. PubMed ID: 20009134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.
    Heringlake S; Schütte A; Flemming P; Schmiegel W; Manns MP; Tillmann HL
    Z Gastroenterol; 2009 May; 47(5):417-23. PubMed ID: 19418409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAFLD and NASH are obesity-independent risk factors in COVID-19: Matched real-world results from the large PINC AI™ Healthcare Database.
    Brozat JF; Ntanios F; Malhotra D; Dagenais S; Katchiuri N; Emir B; Tacke F
    Liver Int; 2024 Mar; 44(3):715-722. PubMed ID: 38110709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.
    Ratziu V; Bonyhay L; Di Martino V; Charlotte F; Cavallaro L; Sayegh-Tainturier MH; Giral P; Grimaldi A; Opolon P; Poynard T
    Hepatology; 2002 Jun; 35(6):1485-93. PubMed ID: 12029634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.
    Doycheva I; Zhang T; Amjad W; Thuluvath PJ
    J Clin Exp Hepatol; 2020; 10(4):296-303. PubMed ID: 32655232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
    Afzali A; Berry K; Ioannou GN
    Liver Transpl; 2012 Jan; 18(1):29-37. PubMed ID: 21932374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.